Authors: KASINA S SANDERSON JA FITZNER JN SRINIVASAN A RAO TN HOBSON LJ RENO JM AXWORTHY DB BEAUMIER PL FRITZBERG AR

Citation: S. Kasina et al., SIMPLIFIED PREFORMED CHELATE PROTEIN RADIOLABELING WITH TC-99M MERCAPTOACETAMIDOADIPOYLGLYCYLGLYCINE (N3S-ADIPATE), Bioconjugate chemistry, 9(1), 1998, pp. 108-117

Authors: BEAUMIER PL BREITZ HB

Citation: Pl. Beaumier et Hb. Breitz, DESIGNER LABELS IN CANCER-TREATMENT, Chemistry and Industry, (18), 1998, pp. 734-736

Authors: FRITZBERG AR BEAUMIER PL BOTTINO BJ RENO JM

Citation: Ar. Fritzberg et al., APPROACHES TO IMPROVED ANTIBODY-MEDIATED AND PEPTIDE-MEDIATED TARGETING FOR IMAGING AND THERAPY OF CANCER, Journal of controlled release, 28(1-3), 1994, pp. 167-173

Authors: STUBBS JB BEAUMIER PL BREITZ HB RENO JM

Citation: Jb. Stubbs et al., COMPARTMENTAL MODELING OF AND RADIATION-DOSE ESTIMATES FOR RE-186 NR-LU-10 MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000158-160000158

Authors: BREITZ HB FISHER DR WEIDEN PL DURHAM JS RATLIFF BA BJORN MJ BEAUMIER PL ABRAMS PG

Citation: Hb. Breitz et al., DOSIMETRY OF RHENIUM-186-LABELED MONOCLONAL-ANTIBODIES - METHODS, PREDICTION FROM TC-99M-LABELED ANTIBODIES AND RESULTS OF PHASE-I TRIALS, The Journal of nuclear medicine, 34(6), 1993, pp. 908-917

Authors: WEIDEN PL BREITZ HB SEILER CA BJORN MJ RATLIFF BA MALLETT R BEAUMIER PL APPELBAUM JW FRITZBERG AR SALK D

Citation: Pl. Weiden et al., RHENIUM-186-LABELED CHIMERIC ANTIBODY NR-LU-13 - PHARMACOKINETICS, BIODISTRIBUTION AND IMMUNOGENICITY RELATIVE TO MURINE ANALOG NR-LU-10, The Journal of nuclear medicine, 34(12), 1993, pp. 2111-2119